Why Is Glenmark Pharmaceuticals Limited (NSE: GLENMARK.NS) Stock Down Today?

Glenmark Pharmaceuticals Limited (NSE: GLENMARK.NS) Summary

Glenmark Pharmaceuticals Limited (NSE: GLENMARK.NS) is trading up +0.13% at $2,194.80, reflecting a positive shift in investor sentiment today. The stock opened at $2,199.90 and has moved between $2,187.60 and $2,208.00 so far.

Trading volume is 299918, which is 57% below its average, and the price action suggests buying interest.

Technically, GLENMARK.NS on the NSE is trading below its 50-day moving average of $2,234.36 and above its 200-day moving average of $2,100.00, indicating short-term weakness but long-term strength.

Meyka's AI assigns GLENMARK.NS a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -8.59% in 1 month ($2,006.22), +10.97% in 1 year ($2,435.66), and +95.82% in 5 years ($4,297.94).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NSE.
Stay informed and make better investment decisions.